Christina Krainbrink, APRN
Payments from drug & device makers
Across 543 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$605
- Nestle Healthcare Nutrition Inc.$565
- Sanofi$452
- plus $3K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 179 | $3,183 |
| Johnson & Johnson | 50 | $1,105 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 70 | $1,060 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $605 |
| Nestle Healthcare Nutrition Inc. | 44 | $565 |
| Sanofi | 21 | $452 |
| Madrigal Pharmaceuticals | 13 | $437 |
| QOL Medical, LLC | 18 | $346 |
| Lilly USA, LLC | 12 | $271 |
| Intercept Pharmaceuticals, Inc. | 12 | $252 |
| Bristol Myers Squibb | 12 | $221 |
| Ardelyx, Inc. | 12 | $200 |
| Ironwood Pharmaceuticals, Inc | 9 | $135 |
| Merck | 8 | $134 |
| Aimmune Therapeutics, Inc. | 4 | $107 |
| Gilead | 4 | $105 |
| Braintree Laboratories, Inc. | 6 | $89 |
| Exact Sciences | 1 | $86 |
| Ipsen Biopharmaceuticals, Inc | 4 | $81 |
| Phathom Pharmaceuticals, Inc. | 6 | $79 |
| Daiichi Sankyo Inc. | 4 | $75 |
| Novo Nordisk | 2 | $59 |
| Redhill Biopharma Inc. | 2 | $56 |
| Ferring Pharmaceuticals Inc. | 3 | $55 |
| Organon | 3 | $54 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| Biocon Biologics Inc | 2 | $36 |
| Pfizer | 2 | $33 |
| AstraZeneca | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
How this compares
$10,007 in reported general payments places this provider in the 95th percentile of 1,501 family providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Reno
- Lisa Hammargren-KuykendallReno$22K
- Martha AiyukReno$15K
- Jocelyn AllenReno$12K
- Kaylie HumphreysReno$11K
- Barbara SzatkowskiReno$10K
- Johanna LeeReno$9K
- Darin OldeReno$9K
- Ruth SkinnerReno$8K
- Anna EllisReno$7K
- Pauline StoltznerReno$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.